Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTF3C6 pseudogene 2 (GTF3C6P2) is annotated as a pseudogene, not as a protein-coding gene or active molecular target[4]. Pseudogenes are sequences similar to known genes but are typically nonfunctional due to mutations or lack of regulatory elements. There is no evidence that GTF3C6P2 encodes a protein, participates in biological pathways, or serves as a therapeutic target. Its only recognized function is as a genomic locus without known biological or disease roles. The canonical, active gene in the family is GTF3C6, encoding a subunit of the general transcription factor IIIC complex involved in RNA polymerase III transcription, but GTF3C6P2 itself is not functionally analogous and is not considered a receptor, enzyme, or any other druggable target[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTF3C6 pseudogene 2 (GTF3C6P2).